Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preservative-free Tafluprost in Newly Diagnosed Glaucoma
NCT04455126Phase 3Completed
- Sponsor
- Alexandria University
- Start
- Apr 2018
- Primary completion
- Dec 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of tafluprost in Glaucoma, sponsored by Alexandria University. Started Apr 2018; status: completed.
02
Drugs
tafluprost
03
Conditions
Glaucoma
Beyond the preview
Go deeper on NCT04455126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04455126.